Combined inhibition of XIAP and BCL2 drives maximal therapeutic efficacy in genetically diverse aggressive acute myeloid leukemia (2021)

First Author: Hashimoto M

Attributed to: Transcriptional Regulation of GATA-1 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s43018-021-00177-w

PubMed Identifier: 35121960

Publication URI: http://europepmc.org/abstract/MED/35121960

Type: Journal Article/Review

Parent Publication: Nature Cancer

Issue: 3

ISSN: 2662-1347